Whitehawk Therapeutics Inc (WHWK) financial statements and ratios from SEC XBRL: revenue $7.14M (TTM), net margin -288.3%, revenue growth -72.5% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $7.14M |
| Net Margin | -288.3% |
| Revenue Growth (YoY) | -72.5% |
| EPS Growth (YoY) | -86.0% |
| FCF Growth (YoY) | 60.1% |
| Price / Book | 2.01 |
| Price / Sales | 32.74 |
| FCF Yield | -77.3% |
| Altman Z-Score | 4.56 (safe) |
| Sector P/E (Healthcare) | 21.7 |
WHWK overview · WHWK earnings · WHWK KPIs · WHWK investor relations · WHWK ownership · WHWK peers · WHWK filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.